Abstract:<h3 class="Heading">Background</h3><p class="Para">Long non-coding RNA PTENP1, the pseudogene of PTEN tumor suppressor, has been reported to exert its tumor suppressive function via modulation of PTEN expression in many malignancies, including breast cancer (BC). However, whether the PTENP1/miR-20a/PTEN axis exists and how it functions in BC progression remains elusive.</p><h3 class="Heading">Methods</h3><p class="Para">The levels of PTENP1, PTEN and miR-20a were measured by qRT-PCR. Furthermore, the breast cancer cells proliferation was further measured by CCK8 assay, colony formation assays, EDU and Ki67 staining. The migratory and invasive ability was determined by transwell assay. Flow cytometry, JC-1 and TUNEL assays were conducted to show the occurrence of apoptosis. Xenograft model was used to show the tumorigenesis of breast cancer cells.</p><h3 class="Heading">Results</h3><p class="Para">We analyzed PTENP1 and PTEN levels in clinical BC samples and cell lines, and found that PTENP1 and PTEN were confirmed and closely correlated with the malignancy of BC cell lines and poor clinical prognosis. Moreover, alteration of PTENP1 affects BC cell proliferation, invasion, tumorigenesis and chemoresistance to adriamycin (ADR). Bioinformatic analysis and dual-luciferase reporter gene assay predicted that PTENP1 was a direct target of miR-20a, which was clarified an alternative effect on BC aggressiveness phenotype. In addition, PTENP1 functioned as an endogenous sponge of miR-20a to regulate PTEN expression, which mediated BC cells proliferation, invasion and drug resistance via activation the phosphatidylinositol-3 kinase (PI3K)/AKT pathway. PI3K inhibitor LY294002 or siAkt also prevented BC cells progression.</p><h3 class="Heading">Conclusion</h3><p class="Para">Collectively, these data indicated that PTENP1/miR-20a/PTEN axis involved in the malignant behaviors of BC cells, illuminating the possible mechanism mediated by PTEN via PI3K/Akt pathway. Targeting PTENP1/miR-20a/PTEN may provide a potential diagnosis and treatment strategy for BC.</p>

Correlation of PTEN signaling pathway and miRNA in breast cancer

PTENP1/miR-20a/PTEN axis contributes to breast cancer progression by regulating PTEN via PI3K/AKT pathway

The association between phosphatase and tensin homolog hypermethylation and patients with breast cancer, a meta-analysis and literature review

The p53/miRNA Axis in Breast Cancer

Mir-183 functions as an oncogene via decreasing PTEN in breast cancer cells

MiR‐548k suppresses apoptosis in breast cancer cells by affecting PTEN/PI3K/AKT signaling pathway

Mir-221/222 Promote Cancer Stem-Like Cell Properties and Tumor Growth of Breast Cancer Via Targeting PTEN and Sustained Akt/NF-κB/COX-2 Activation.

MicroRNAs that regulate PTEN as potential biomarkers in colorectal cancer: a systematic review

A subgroup of microRNAs defines PTEN-deficient, triple-negative breast cancer patients with poorest prognosis and alterations in RB1, MYC, and Wnt signaling

Regulation of the tumor suppressor PTEN by natural anticancer compounds

MicroRNA-1297 Contributes to Tumor Growth of Human Breast Cancer by Targeting PTEN/PI3K/AKT Signaling

MicroRNAs as important players in regulating cancer through PTEN/PI3K/AKT signalling pathways

Prognostic and Predictive Implications of PTEN in Breast Cancer: Unfulfilled Promises but Intriguing Perspectives

The cellular signaling and regulatory role of protein phosphatase in tumor diagnosis: Upstream miRNAs of PTEN

MiR-21 and mRNA PTEN Expression Levels and Biomarker Potential in Breast Cancer

Inhibition of the AKT/mTOR pathway negatively regulates PTEN expression via miRNAs

Decoding PTEN: from biological functions to signaling pathways in tumors

miR-221/222 promote cancer stem-like cell properties and tumor growth of breast cancer via targeting PTEN and sustained Akt/NF-κB/COX-2 activation

The prognostic effect of PTEN expression status in colorectal cancer development and evaluation of factors affecting it: miR-21 and promoter methylation

Impact of microRNA variants on PI3K/AKT signaling in triple-negative breast cancer: comprehensive review

The Regulatory Role of Pivotal MicroRNAs in the AKT Signaling Pathway in Breast Cancer